ʻO Azithromycin
| inoa huahana | AZITHROMYCINA | ||
| CAS | 83905-01-5 | ||
| KULA HS | 29419090 | ||
| Hoʻopau | 5 makahiki | ||
| Kūlana | EP o kēia manawa | ||
| Ka nana aku | Keʻokeʻo a aneane keʻokeʻo crystalline pauda | ||
| Ka hikiwawe | ʻAʻole hiki ke hoʻoheheʻe ʻia i ka wai, hiki ke hoʻoheheʻe ʻia i ka ethanol anhydrous a me ka inmethylene chloride | ||
| ʻIkepiliIR | Kūlike me Azithromycin RSS pono e akaka a kala ʻole .Ma waena o 9.0 a me l1.0Ma waena o -45 a me -49 | ||
| Mea pili | haumia L | ≤0.5% | |
| haumia M | ≤0.5% | ||
| haumia E | ≤0.5% | ||
| haumia F | ≤0.5% | ||
| ʻO ka haumia D a me J | ≤0.5% | ||
| haumia I | ≤0.5% | ||
| haumia C | ≤0.5% | ||
| haumia N | ≤0.5% | ||
| haumia H | ≤0.5% | ||
| haumia A | ≤0.5% | ||
| haumia P | ≤0.5% | ||
| haumiaO | ≤0.5% | ||
| haumia G | ≤0.2% | ||
| haumia B | ≤2.0% | ||
| ʻO nā mea haumia ʻē aʻe | ≤0.2% | ||
| Huina haumia | ≤3.0% | ||
| Metala kaumahas | ≤25ppm | ||
| Wai | 1.8%-6.8% | ||
| Lehu hū | ≤0.2% | ||
| Assay Ma ke kumu anhydrous | 98.3% | ||
| Nā mea hoʻoheheʻe koena | Acetone | ≤3200ppm | |
| Methanol | ≤3000ppm | ||
| Dichloromethane | ≤600ppm | ||
| ʻAno nui | 0.35~0.65g/ml | ||
| Paʻi paʻa | 0.65~0.85g/ml | ||
| Ka hāʻawi ʻana i ka nui o nā ʻāpana | ≥80% 40 mesh | ||
| hana | Loaʻa i ka Carvedilol ka puʻuwai ikaika a me nā hopena neuroprotective: ʻaʻole like me nā antagonists β-receptor maʻamau, ʻo ka hoʻohana lōʻihi o kēia huahana i nā mea maʻi hypertensive ʻaʻole hiki ke hoʻonui wale i nā kīʻaha coronary a me nā renal, e hoʻemi i ke kūʻē ʻana o nā vascular peripheral, akā e hōʻemi hoʻi i ka ʻōnaehana systemic. A me ka pulmonary circulation resistance, e hoʻomalu pono i ke koko kiʻekiʻe. He hopena pale kēia huahana i ka hana renal, ʻaʻole e hoʻololi i ke kahe o ke koko, akā e hōʻemi i ka microalbuminuria, e hōʻemi i ka pale ʻana i ka renal vascular, a he hopena hoʻoponopono maikaʻi i nā lipids koko. | ||
E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou
